Cargando…
The EVO ICL for Moderate Myopia: Results from the US FDA Clinical Trial
PURPOSE: To evaluate the safety and effectiveness of collamer posterior chamber phakic refractive lenses with a central port design (EVO and EVO+ Sphere and Toric implantable collamer lenses [ICLs]) for correction of moderate myopia with or without astigmatism. PATIENTS AND METHODS: Six-month result...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738966/ https://www.ncbi.nlm.nih.gov/pubmed/36510599 http://dx.doi.org/10.2147/OPTH.S393422 |